Not certain on that. But let's look at the PR that Reid put out. He commented that Treaty was going to focus on what he considered bigger opportunities, well essentially that's what he meant in one of his PR's. Since the Brown came in with not much fanfare from anyone, I suspect it didn't measure up and perhaps it leaves the company with a decision to either hold it or sell it. I don't have that answer, but you might give them a call and find out. Now, the McComas is another story. Sure, supposedly York screwed it up, but could the company somehow consider what the production opportunity might have been. After all, there was that video that showed oil flowing our of the tubing. Usually, that's a pretty positive picture. But, we haven't heard anything else about it either. Here's a personal comment. I really don't believe the company should have to PR everything that they are doing. I don't buy the company stock for daily updates, nor even weekly ones. However, there are some protocols I would like to see the company follow and those would go along with what the SEC has formulated in their regs regarding public companies. Treaty doesn't do this all the time in my opinion, and they should. That doesn't mean everything about an individual well. Only if it means something of value of at least 10% of the company worth. And that's not market cap.
Not certain on that. But let's look at the PR that Reid
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Lumexa Imaging's Investor Conference Push: Any Real Substance?
Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...
Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts
Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...
Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms
Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...
Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success
Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...
Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration
GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...
Continue Reading